News
Anti-rights and anti-gender pushes are driven by political, conservative, and religious bodies that frame wrong ...
From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July 2025.
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
Ending the spread of HIV in Arizona may become more difficult if federal funding is cut or eliminated. Phoenix is trying to end new HIV infections by 2030.
For example, PEPFAR has paid for the procurement and distribution of PrEP, a medication that prevents HIV infections in high-risk individuals such as couples where one is HIV-positive and one is ...
CHENNAI: Gilead Sciences has achieved another milestone in its efforts to bring in a preventive drug to curb the still rapidly spreading HIV epidemic, in the wo ...
Last year, there were about 630,000 AIDS deaths worldwide and more than 40 million people are estimated to have HIV, according to UNAIDS. UNAIDS chief Byanyima has previously suggested that President ...
UNAIDS chief Byanyima has previously suggested that President Donald Trump make a deal with Gilead to produce and license its “magical” prevention drug lenacapavir across the world to the ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end transmission.
UNAIDS chief Byanyima has previously suggested that President Donald Trump make a deal with Gilead to produce and license its "magical" prevention drug lenacapavir across the world to the millions of ...
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results